missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Girentuximab Recombinant Monoclonal Antibody
Description
For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °.
Girentuximab is a monoclonal chimeric (mouse/human) antibody directed against carbonic anhydrase IX, an antigen expressed in 95% of clear cell renal cell carcinomas (RCC).
Specifications
Specifications
| Antigen | Girentuximab Chimeric |
| Anwendungen | ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance |
| Klassifikation | Recombinant Monoclonal |
| Konzentration | 1 mg/mL |
| Konjugat | Unconjugated |
| Zusammensetzung | 25 mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2 |
| Gen-Alias | cG250; WX-G250 |
| Wirtsspezies | Human |
| Reinigungsverfahren | Protein A |
| Menge | 1 mg |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?